Owlet

Also: Baby tech company Owlet and diagnostics-focused Cue Health plan on submitting for regulatory clearances this year.

The baby tech company rolled out a new product called the Owlet Dream Sock Plus, which can be used on children up to age 5 or up to 55 pounds. 

This news comes after the FDA sent the company a warning letter regarding its smart socks. 

The stock took a tumble in October following the letter. 

The company is currently trading under OWLT on the New York Stock Exchange. 

Also: Dexcom promotes Jereme Sylvain to EVP and CFO; Amalgam Rx snags CMS' Jennifer Main as COO and CFO.

The company currently sells connected wearables and smart monitors to consumers, but said that it will be seeking FDA authorization for new products with broader indications and telehealth capabilities down the line.

Last week CES brought innovators from around the world to Las Vegas.

While most wearable baby monitors are designed with the intention to give parents peace of mind, some experts warn they may do just the opposite.

Owlet Baby Care, a tech startup developing smart socks for monitoring infants' vital signs, raised $6 million in venture funding and another $1 million in the form of an NIH Grant.